HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in HCW Biologics Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −3 vs. Q1 2026
- Shares held
- 103.5K
- −346.3K (−77.0%) vs. Q1 2026
- Total value
- $515.7K
- +$354.8K (+220.6%) vs. Q1 2026
- New holders
- 3
- 2 more added
- Sold out
- 6
- 7 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HCWB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $515.7K |
| Q1 2026 | 15 | $160.8K |
| Q4 2025 | 14 | $424.1K |
| Q3 2025 | 10 | $456.9K |
| Q2 2025 | 8 | $85.5K |
| Q1 2025 | 15 | $326.0K |
| Q4 2024 | 18 | $1.40M |
| Q3 2024 | 16 | $625.6K |
| Q2 2024 | 19 | $784.3K |
| Q1 2024 | 20 | $1.90M |
| Q4 2023 | 19 | $1.30M |
| Q3 2023 | 14 | $1.93M |
| Q2 2023 | 13 | $2.17M |
| Q1 2023 | 13 | $1.22M |
| Q4 2022 | 14 | $1.50M |
| Q3 2022 | 13 | $1.50M |
| Q2 2022 | 13 | $1.25M |
| Q1 2022 | 13 | $1.48M |
| Q4 2021 | 13 | $855.0K |
| Q3 2021 | 9 | $512.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding HCW Biologics Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 52,138 | $260.2K | 0.00% | +38,004+268.9% | Added |
| Citadel Advisors LLC | 19,942 | $99.5K | 0.00% | −6,141−23.5% | Reduced |
| HRT Financial LP | 13,583 | $67.0K | 0.00% | −252,810−94.9% | Reduced |
| Vanguard Fiduciary Trust Co | 6,510 | $32.5K | 0.00% | +4,607+242.1% | Added |
| Tower Research Capital LLC (TRC) | 4,117 | $20.5K | 0.00% | −10,722−72.3% | Reduced |
| Connective Capital Management, LLC | 3,338 | $16.7K | 0.01% | +3,338 | New |
| Vanguard Capital Management LLC | 2,003 | $9.99K | 0.00% | −10,020−83.3% | Reduced |
| Golden State Wealth Management, LLC | 1,667 | $8.32K | 0.00% | −8,333−83.3% | Reduced |
| Barclays PLC | 191 | $953 | 0.00% | +191 | New |
| Advisor Group Holdings, Inc. | 4 | $20 | 0.00% | −22−84.6% | Reduced |
| Caitong International Asset Management Co., Ltd | 11 | $10 | 0.00% | +11 | New |
| UBS Group AG | 1 | $5 | 0.00% | −9,220−100.0% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −47,809−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −35,886−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −10,528−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold out |